AVEO Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch AVEO and buy or sell other stocks, ETFs, and their options commission-free!

About AVEO

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. 

CEO
Michael P. Bailey, MBA
CEOMichael P. Bailey, MBA
Employees
Employees
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2001
Founded2001
Employees
Employees

AVEO Key Statistics

Market cap
521.45M
Market cap521.45M
Price-Earnings ratio
-17.81
Price-Earnings ratio-17.81
Dividend yield
Dividend yield
Average volume
545.54K
Average volume545.54K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$15.00
52 Week high$15.00
52 Week low
$3.06
52 Week low$3.06

People also own

Based on the portfolios of people who own AVEO. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.